A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 78 GBX 5.41% Market Closed
Market Cap: 29.5m GBX

Operating Margin
Arecor Therapeutics PLC

-109.6%
Current
-286%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-109.6%
=
Operating Profit
-5.5m
/
Revenue
5.1m

Operating Margin Across Competitors

No Stocks Found

Arecor Therapeutics PLC
Glance View

Market Cap
29.5m GBX
Industry
Biotechnology

Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. The firm targets improving patient care by bringing medicines to market through the existing therapeutic products. The company partners with global pharmaceutical and biotechnology companies to apply the Arestat technology to their products under a technology licensing model. These products can be at any stage in development from early phase clinical development through to products that are already on the market. The areas of applications of the technology are biologicals, biosimilars, therapeutic vaccines and therapeutic peptides.

AREC Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-109.6%
=
Operating Profit
-5.5m
/
Revenue
5.1m
What is the Operating Margin of Arecor Therapeutics PLC?

Based on Arecor Therapeutics PLC's most recent financial statements, the company has Operating Margin of -109.6%.

Back to Top